Each of our brands is guided by a clear purpose: improving patient outcomes in our key focus areas of ophthalmology and musculoskeletal disorders
Who we are
TRB is a Swiss-based biopharma company headquartered in Geneva, with global reach in ophthalmology, musculoskeletal health, and neurology. Since 1980, we’ve developed and produced trusted therapies that improve patient comfort and well-being.
TRB at a glance
1980 Founded in Switzerland
1100+ Employees
70+ Countries served
21 Branches
3 Production sites
Swiss firm, global presence
Swiss firm, global presence
Our international presence helps us stay close to patients and professionals—working with local partners to respond quickly in changing environments.
Our worldwide networkTRB executive committee
As a family-owned company, our values are lived across the organisation, from leadership to the factory floor.
Meet the TRB executive committee
High standards mean high quality
TRB’s sites pair advanced technology with rigorous quality standards to ensure excellence in biotechnology and sustainable production.
Our expertise
With over 30 years of expertise in biotechnology, we develop high-quality, evidence-based therapies designed to improve patients wellbeing and long-term quality of life. Expertise in hyaluronic acid, diacerein, and GM1 ganglioside underpins a portfolio of trusted and effective therapies across ophthalmology, rheumatology, orthopaedics and neurology.
Trusted healthcare solutions
